Solid Tumor

Showing 76 - 100 of 763

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Urinary System Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Mar 26, 2023

Solid Tumor Trial in San Antonio, Tyler, Spokane (TU2218 + Pembrolizumab)

Recruiting
  • Solid Tumor
  • TU2218 + Pembrolizumab
  • San Antonio, Texas
  • +2 more
Mar 26, 2023

Solid Tumor Trial (UCLM802 Cell Injection)

Not yet recruiting
  • Solid Tumor
  • UCLM802 Cell Injection
  • (no location specified)
Mar 7, 2023

Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

Not yet recruiting
  • Refractory Tumor
  • Solid Tumor
  • Dendritic Cell Vaccine
  • +2 more
  • Kaohsiung, Taiwan
  • +2 more
Mar 2, 2023

Solid Tumor Trial in Beijing (Hemay181)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 27, 2023

Solid Tumor Trial in Kunming (RD14-01)

Recruiting
  • Solid Tumor
  • RD14-01
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Feb 18, 2023

Solid Tumor Trial (HER2-E-CART cells)

Not yet recruiting
  • Solid Tumor
  • HER2-E-CART cells
  • (no location specified)
Feb 16, 2023

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)

Not yet recruiting
  • Solid Tumor
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Feb 9, 2023

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

Exploratory Drug Interaction Study Between SMIs and DOACs

Recruiting
  • Solid Tumor
  • Cancer, Lung
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Feb 7, 2023

    Solid Tumor Trial in China (GT201)

    Recruiting
    • Solid Tumor
    • GT201
    • Zhengzhou, Henan, China
    • +4 more
    Feb 6, 2023

    Solid Tumor Trial in Denver, Fairfax (PYX-106)

    Recruiting
    • Solid Tumor
    • Denver, Colorado
    • +1 more
    Feb 9, 2023

    Solid Tumor Trial in Shanghai (GT201)

    Recruiting
    • Solid Tumor
    • GT201
    • Shanghai, Shanghai, China
      Renji Hospital Affiliated to Shanghai Jiaotong University School
    Feb 1, 2023

    Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

    Recruiting
    • Solid Tumor
    • Haematological Malignancy
    • Belfast, United Kingdom
    • +24 more
    Jan 31, 2023

    Solid Tumor, Advanced Solid Tumor Trial (PYX-201)

    Not yet recruiting
    • Solid Tumor
    • Advanced Solid Tumor
    • (no location specified)
    Feb 9, 2023

    Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

    Not yet recruiting
    • Hematologic Malignancy
    • +2 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 6, 2023

    Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

    Not yet recruiting
    • Solid Tumor
    • +2 more
    • (no location specified)
    Jan 28, 2023